Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. R.A. (Robert) Schoevers
University Medical Center Groningen

prof. dr. R.A. (Robert) Schoevers

Hoogleraar en afdelingshoofd Psychiatrie UMCG

Publicaties

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice

Can Physical Activity, Sleep Parameters, and Sleep-Wake Patterns Predict Outcome of Combined Chronotherapy in Mood Disorder During Routine Clinical Practice?: An Exploratory Study

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients

Corrigendum to “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression” [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532, (S0165032724020494), (10.1016/j.jad.2024.12.061)]

Effects of ketamine on sleep and circadian rhythmicity in major depressive disorder and bipolar disorder: A systematic review

Feasibility of diagnosing major depressive disorder with a panel of serum and urine biomarkers

Ketamine addiction following a single sub-anaesthetic ketamine treatment for acute suicidality in a psychiatrically multimorbid patient: Case report

Modeling effect: How treatment intensity and duration impact depression recurrence

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach

Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis

Pers/media

143. Psychedelics for Palliative care with Prof Robert Schoevers

Praten, pillen, paddo's

Worden psychedelica medicijnen tegen psychische klachten?

Nederland is nog niet zover, maar Tsjechië gaat paddotherapie legaliseren

First Patient Included Marks Major Milestone in EU-Funded Clinical Trial

Psychiater Robert Schoevers gaat op zoek naar betekenis

Farmaci psichedelici: al via il primo trial europeo sul distress nel fine vita

Wat hebben ketamine en depressie met elkaar te maken?

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 4 – KwaliteitsonderwijsSDG 5 – GendergelijkheidSDG 8 – Fatsoenlijk werk en economische groeiSDG 9 – Industrie, innovatie en infrastructuurSDG 11 – Duurzame steden en gemeenschappenSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.